Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

LBRX — LB PHARMACEUTICALS INC SEC Filings | FilingIndex

LBRXNasdaq

LB PHARMACEUTICALS INC

Pharmaceutical Preparations · DE · CIK 1691082

Develops pharmaceutical product candidates, primarily LB-102, through research and clinical trials

red 8-K · 90d

+ Watch View on EDGAR ↗

$815M

Market cap

$32.64

Last close

+2.3%

1D

+9.3%

5D

367K

Volume

Price · last 39 sessions+2.5%

May 4L $27.02 · H $32.88Jun 29

20

Total filings

Jun 10, 2026

Last filing

12/31

Fiscal year end

All 8-K · 11 S-1 · 2 10-Q · 2 10-K · 1 S-1/A · 1 DEF 14A · 1 SC 13D/A · 1 424B4 · 1

8-KExecutive ChangeJun 10, 2026 8-KShareholder VoteJun 9, 2026 8-KResults of OperationsMay 12, 2026 8-KResults of OperationsMar 26, 2026 8-KExecutive ChangeMar 16, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

APGEApogee Therapeutics, Inc.🔥$6.7B+0.1%VKTXViking Therapeutics, Inc.$3.3B+3.9%TBPHTheravance Biopharma, Inc.$857.8M-3.2%ADCTADC Therapeutics SA$133.6M+1.0%NKTRNEKTAR THERAPEUTICS

Executive Change · Reg FD Disclosure

Mar 10, 2026

8-KMaterial Agreement · Equity IssuanceFeb 5, 2026

8-KMaterial AgreementNov 13, 2025

8-KCompany UpdateNov 12, 2025

8-KResults of OperationsNov 6, 2025

8-KBylaw AmendmentSep 12, 2025

$2.0B

+2.7%

SPRBSPRUCE BIOSCIENCES, INC.$142.8M+1.4%